Filing Flows › Lunai Bioworks (LNAI) › Q3 FY26
Lunai Bioworks (LNAI) Q3 FY26 earnings results (third quarter fiscal 2026)
10-Q filed May 15, 2026
Lunai Bioworks (LNAI) reported revenue of $21K for the third quarter fiscal 2026 (Q3 FY26).
Lunai Bioworks, Q3 FY26: revenue $21K, net loss $2.6M, operating cash flow −$1.0M. The chart follows the revenue to costs, profit and cash.
| Q3 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $21K | — | — |
| Operating profit | −$1.5M | — | — |
| Net earnings | −$2.6M | — | — |
| Operating cash flow | −$1.0M | — | — |
What changed
Revenue was $21K in Q3 FY26.
Gross margin was 100.0%. Operating costs exceeded revenue by $1.5M, an operating margin of -7054.1%. The quarter ended with a net loss of $2.6M.
Operating cash flow was −$1.0M. Non-cash charges added back $11K of depreciation and amortization and $169K of share-based compensation. Working capital and other items added $1.4M.
Questions
What was Lunai Bioworks' revenue in the third quarter fiscal 2026?
Lunai Bioworks (LNAI) reported revenue of $21K for the third quarter fiscal 2026 (Q3 FY26).
Source: Lunai Bioworks 10-Q on SEC EDGAR.